However, in spite of promising results of preclinical studies showing that defects of FRDA animal models and cells isolated from patients’ biopsies are partially rescued by promoting NRF2 stability and by activating the NRF2 signalling pathway (Figure 1), in most cases, clinical data have yielded conflicting results. Here, NFE2L2 is linked to Friedreich ataxia.